The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Epidemiology of Parkinson Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,246
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., Zaccai, J., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,689
Parkinson, J. (2002) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.14.2.223 · Cited by 1,628
Prevalence and Characteristics of Dementia in Parkinson Disease: An 8-Year Prospective Study
Aarsland, D., Andersen, K., Larsen, J. P., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,401
Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
MDS research criteria for prodromal Parkinson's disease
Berg, D., Postuma, R. B., Adler, C. H., Bloem, B. R., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G., Joseph, L., et al. (2015) · Movement Disorders · doi:10.1002/mds.26431 · Cited by 1,309
A systematic review of prevalence studies of depression in Parkinson's disease
Reijnders, J. S. A. M., Ehrt, U., Weber, W. E. J., Aarsland, D., & Leentjens, A. F. G. (2008) · Movement Disorders · doi:10.1002/mds.21803 · Cited by 1,239
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130
Vagotomy and subsequent risk of Parkinson's disease
Svensson, E., Horváth‐Puhó, E., Thomsen, R. W., Djurhuus, J. C., Pedersen, L., Borghammer, P., & Sørensen, H. T. (2015) · Annals of Neurology · doi:10.1002/ana.24448 · Cited by 806
MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI
Litvan, I., Aarsland, D., Adler, C. H., Goldman, J. G., Kulisevsky, J., Mollenhauer, B., Rodriguez‐Oroz, M. C., Tröster, A. I., & Weintraub, D. (2011) · Movement Disorders · doi:10.1002/mds.23823 · Cited by 805
Gender differences in Parkinson's disease
Haaxma, C. A., Bloem, B. R., Borm, G. F., Oyen, W. J. G., Leenders, K. L., Eshuis, S., Booij, J., Dluzen, D. E., & Horstink, M. W. I. M. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.103788 · Cited by 741
Olfactory dysfunction in Parkinson disease
Doty, R. L. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.80 · Cited by 737
Non-motor symptoms in Parkinson's disease
Pfeiffer, R. F. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.004 · Cited by 644
Epidemiology of parkinson’s disease
Tanner, C. M., & Goldman, S. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70259-0 · Cited by 640
Martinez‐Martin, P., Schapira, A. H. V., Stocchi, F., Sethi, K., Odin, P., MacPhee, G., Brown, R. G., Naidu, Y., Clayton, L., Abe, K., et al. (2007) · Movement Disorders · doi:10.1002/mds.21586 · Cited by 554
Thenganatt, M. A., & Jankovic, J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6233 · Cited by 506
Sex differences in Parkinson’s disease
Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.02.002 · Cited by 489
Changes in motor subtype and risk for incident dementia in Parkinson's disease
Alves, G., Larsen, J. P., Emre, M., Wentzel‐Larsen, T., & Aarsland, D. (2006) · Movement Disorders · doi:10.1002/mds.20897 · Cited by 434
Pesticides and Parkinson’s Disease—Is There a Link?
Brown, T. P., Rumsby, P. C., Capleton, A. C., Rushton, L., & Levy, L. S. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8095 · Cited by 430
Functional Decline in Parkinson Disease
Jankovic, J., & Kapadia, A. S. (2001) · Archives of Neurology · doi:10.1001/archneur.58.10.1611 · Cited by 427
Randomized Clinical Trial of 3 Types of Physical Exercise for Patients With Parkinson Disease
Shulman, L. M., Katzel, L. I., Ivey, F. M., Sorkin, J. D., Favors, K., Anderson, K. E., Smith, B. A., Reich, S. G., Weiner, W. J., & Macko, R. F. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.646 · Cited by 410
Apathy in Parkinson's disease: A systematic review and meta‐analysis
den Brok, M. G. H. E., van Dalen, J. W., van Gool, W. A., Moll van Charante, E. P., de Bie, R. M. A., & Richard, E. (2015) · Movement Disorders · doi:10.1002/mds.26208 · Cited by 376
Neurologist care in Parkinson disease: A utilization, outcomes, and survival study
Willis, A. W., Schootman, M., Evanoff, B. A., Perlmutter, J. S., & Racette, B. A. (2011) · Neurology · doi:10.1212/wnl.0b013e31822c9123 · Cited by 303
Traumatic brain injury in later life increases risk for Parkinson disease
Gardner, R. C., Burke, J. F., Nettiksimmons, J., Goldman, S., Tanner, C. M., & Yaffe, K. (2015) · Annals of Neurology · doi:10.1002/ana.24396 · Cited by 285
Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease
Martinez-Martin, P., Falup Pecurariu, C., Odin, P., Hilten, J. J., Antonini, A., Rojo-Abuin, J. M., Borges, V., Trenkwalder, C., Aarsland, D., Brooks, D. J., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6392-3 · Cited by 282
Nonpharmacological treatments for patients with Parkinson's disease
Bloem, B. R., de Vries, N. M., & Ebersbach, G. (2015) · Movement Disorders · doi:10.1002/mds.26363 · Cited by 272
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
Katzenschlager, R., Head, J., Schrag, A., Ben-Shlomo, Y., Evans, A., & Lees, A. J. (2008) · Neurology · doi:10.1212/01.wnl.0000310812.43352.66 · Cited by 271
Schwarzschild, M. A., Ascherio, A., Beal, M. F., Cudkowicz, M. E., Curhan, G. C., Hare, J. M., Hooper, D. C., Kieburtz, K. D., Macklin, E. A., Oakes, D., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5528 · Cited by 243
The past, present, and future of telemedicine for Parkinson's disease
Achey, M., Aldred, J. L., Aljehani, N., Bloem, B. R., Biglan, K. M., Chan, P., Cubo, E., Ray Dorsey, E., Goetz, C. G., Guttman, M., et al. (2014) · Movement Disorders · doi:10.1002/mds.25903 · Cited by 169
Gasser, T., Hardy, J., & Mizuno, Y. (2011) · Movement Disorders · doi:10.1002/mds.23637 · Cited by 166
Sakakibara, R., Panicker, J., Finazzi‐Agro, E., Iacovelli, V., Bruschini, H., & The Parkinson's Disease Subcomittee, T. N. P. C. I. T. I. C. S. (2016) · Neurourology and Urodynamics · doi:10.1002/nau.22764 · Cited by 162
Bican, O., Minagar, A., & Pruitt, A. A. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2012.09.009 · Cited by 161
Parkinson disease and smoking revisited: Ease of quitting is an early sign of the disease
Ritz, B., Lee, P.-C., Lassen, C. F., & Arah, O. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000879 · Cited by 160
Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial
van der Marck, M. A., Bloem, B. R., Borm, G. F., Overeem, S., Munneke, M., & Guttman, M. (2012) · Movement Disorders · doi:10.1002/mds.25194 · Cited by 157
The motor phenotype of Parkinson's disease in relation to age at onset
Wickremaratchi, M. M., Knipe, D. W., Sastry, B. S. D., Morgan, E., Jones, A., Salmon, R., Weiser, R., Moran, M., Davies, D., Ebenezer, L., et al. (2011) · Movement Disorders · doi:10.1002/mds.23469 · Cited by 153
Sleep disorders in Parkinson’s disease
Stocchi, F., Barbato, L., Nordera, G., Berardelli, A., & Ruggieri, S. A. (1998) · Journal of Neurology · doi:10.1007/pl00007731 · Cited by 150
Valkovič, P., Minár, M., Singliarova, H., Haršány, J., Hanáková, M., Martinkova, J., & Benetin, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136541 · Cited by 147
McCarter, S. J., Louis, E. K. S., & Boeve, B. F. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0253-z · Cited by 137
Rees, K., Stowe, R. L., Patel, S., Ives, N. J., Breen, K. C., Clarke, C. E., & Ben‐Shlomo, Y. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008454 · Cited by 130
Prospective Study of Statin Use and Risk of Parkinson Disease
Gao, X., Simon, K. C., Schwarzschild, M. A., & Ascherio, A. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.1060 · Cited by 129
Nonmotor Symptoms in Parkinson's Disease
Sung, V., & Nicholas, A. P. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2013.04.013 · Cited by 123
Do nonmotor symptoms in Parkinson's disease differ from normal aging?
Krishnan, S., Sarma, G., Sarma, P. S., & Kishore, A. (2011) · Movement Disorders · doi:10.1002/mds.23826 · Cited by 121
Ophthalmological features of Parkinson disease
Safranow, K. (2014) · Medical Science Monitor · doi:10.12659/msm.890861 · Cited by 119
Diet and Parkinson's disease I
Hellenbrand, W., Seidler, A., Boeing, H., Robra, B., Vieregge, P., NISCHAN, P., Joerg, J., Oertel, W. H., Schneider, E., & Ulm, G. (1996) · Neurology · doi:10.1212/wnl.47.3.636 · Cited by 119
Parkinson Study Group (2013) · Movement Disorders · doi:10.1002/mds.25639 · Cited by 113
Mortality in Parkinson's disease: A 20‐year follow‐up study
Diem‐Zangerl, A., Seppi, K., Wenning, G. K., Trinka, E., Ransmayr, G. N., Oberaigner, W., & Poewe, W. H. (2009) · Movement Disorders · doi:10.1002/mds.22414 · Cited by 105
Mortality in Parkinson's disease, a 20‐year follow‐up study
Diem‐Zangerl, A., Seppi, K., Oberaigner, W., & Poewe, W. H. (2010) · Movement Disorders · doi:10.1002/mds.22934 · Cited by 99
Relationship between sleep disorders and other non-motor symptoms in Parkinson's disease
Kurtis, M. M., Rodríguez‐Blázquez, C., & Martínez‐Martín, P. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.07.026 · Cited by 90
Moretto, A., & Colosio, C. (2012) · Toxicology · doi:10.1016/j.tox.2012.11.021 · Cited by 83
Nonmotor symptoms of Parkinson’s disease
Zesiewicz, T., Sullivan, K. L., & Hauser, R. A. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.12.1811 · Cited by 75
Alcohol Consumption and Parkinson’s Disease Risk: A Review of Recent Findings
Bettiol, S. S., Rose, T. C., Hughes, C. J., & Smith, L. A. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150533 · Cited by 73
Nonmotor symptoms more closely related to Parkinson's disease: Comparison with normal elderly
Kim, H.-S., Cheon, S., Seo, J., Ryu, H.-J., Park, K.-W., & Kim, J. W. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.10.004 · Cited by 57
Head injury and risk for Parkinson disease
Kenborg, L., Rugbjerg, K., Lee, P., Ravnskjær, L., Christensen, J., Ritz, B. R., & Lassen, C. F. (2015) · Neurology · doi:10.1212/wnl.0000000000001362 · Cited by 49
Lower urinary tract dysfunction in patients with parkinsonism and other neurodegenerative disorders
Winge, K. (2015) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63247-0.00019-5 · Cited by 46
Does a specialist unit improve outcomes for hospitalized patients with Parkinson's disease?
Skelly, R., Brown, L. S., Fakis, A., Kimber, L., Downes, C., Lindop, F., Johnson, C., Bartliff, C., & Bajaj, N. P. S. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.09.015 · Cited by 42
Artistic occupations are associated with a reduced risk of Parkinson’s disease
Haaxma, C. A., Borm, G. F., van der Linden, D., Kappelle, A. C., & Bloem, B. R. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7828-y · Cited by 9
McCarter, S. J., Louis, E. K. S., & Boeve, B. F. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0261-z · Cited by 6
Duarte, J., Olmos, L. M. G., Mendoza, A., Pueyo, Á. M., & Clavería, L. E. (2015) · Neurodegenerative Diseases · doi:10.1159/000369531 · Cited by 2
Cited by
Balestrino, R., & Schapira, A. H. V. (2020) · European Journal of Neurology · doi:10.1111/ene.14108 · Cited by 1,508
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
Targeting Metalloenzymes for Therapeutic Intervention
Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 270
da Silva, F. C., Iop, R. D. R., de Oliveira, L. C., Boll, A. M., de Alvarenga, J. G. S., Gutierres Filho, P. J. B., de Melo, L. M. A. B., Xavier, A. J., & da Silva, R. (2018) · PLOS ONE · doi:10.1371/journal.pone.0193113 · Cited by 189
Speech-based characterization of dopamine replacement therapy in people with Parkinson’s disease
Norel, R., Agurto, C., Heisig, S., Rice, J. J., Zhang, H., Ostrand, R., Wacnik, P. W., Ho, B. K., Ramos, V. L., & Cecchi, G. A. (2020) · npj Parkinson's Disease · doi:10.1038/s41531-020-0113-5 · Cited by 45
Metadata
- Authors
- Lee, A., & Gilbert, R. M.
- Venue
- Neurologic Clinics
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 34
- Issue
- 4
- Pages
- 955-965
- ISSN
- 0733-8619 (ISSN-L)
- OpenAlex
- W2507172980
- Cited by
- 366
- References
- 65
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.